Navigation Links
CSHL team develops mouse models of leukemia that predict response to chemotherapy
Date:3/31/2009

. This incorrect fusion is thought to create cancer-causing genes, or "oncogenes," that encode so-called fusion proteins. It's the proteins that are the most immediate "cause" of cancer. They profoundly disturb the developmental program of cells.

Both oncogenic mutations identified by Lowe's team in AML patients have been well studied. The oncogene AML1/ETO previously has been associated with a favorable therapeutic outcome in people, while fusion oncogenes involving the MLL gene have been associated with an adverse outcome. To design an animal model that predicts these outcomes, the team introduced each mutation individually into stem and progenitor cells along with another oncogene, called Nras, which also appears frequently in human AML and is commonly found in concert with AML1/ETO and MLL fusion genes.

These altered stem cells were transplanted into mice that were first treated with radiation to destroy existing bone marrow cells. The altered stem cells then took over the "host" bone marrow and promoted the development of leukemia. To track leukemia onset and response to therapy, the scientists tagged all leukemia cells with a gene from fireflies that encodes an enzyme called luciferase, which makes leukemia cells glow and detectable by a ultrasensitive camera. Within weeks, the mice developed leukemias that showed the same genetic and pathological features as human AML.

"We were therefore certain," says Lowe, "that these animals were good models for studying the impact of cancer's genetic heterogeneity on therapy response and getting a correct read-out in terms of outcome prediction."

Sensitivity vs. resistance to chemotherapy

Experiments in which the team treated the mice with the same chemotherapy regimen administered to AML patients have proved Lowe to be correct. Just as in humans, leukemias in mice that received the AML1/ETO oncogene were also sensitive to chemotherapy and soon regressed, whereas ML
'/>"/>

Contact: Hema Bashyam
bashyam@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. MIT student develops new innovations to selectively kill cancer cells
2. When acute hepatitis develops into chronic hepatitis
3. Fujitsu Develops HDD Security Technology Based on Opal SSC Standards
4. MIT develops new way to fuse cells
5. Hypertension develops early, silently, in African-American men
6. Iowa State researcher develops new treatment method for canine eye diseases
7. Lighting research center develops framework for assessing light pollution
8. AgriLife Research breeder develops drought-tolerant corn
9. Cocaine: How addiction develops
10. UCF professor develops vaccine to protect against black plague bioterror attack
11. Consortium develops new method enabling routine targeted gene modification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/13/2015)... YORK , April 13, 2015 ... by TechSci Research, "Global Biometrics Market Forecast & Opportunities, ... register a CAGR of around 14% till 2020. ... governments for large scale implementation and review of ... and launch of new products with greater efficiency, ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... working on innovative energy supply solutions are included in ... Science Foundation program aimed at promoting environmental sustainability. ... a physics professor, were among the 101 scientists and ... for the Sustainable Chemistry, Engineering and Materials, or SusChEM, ...
... A drug currently used to treat intestinal worms ... which untreated can erode the structuresincluding bonethat hold the ... of print in Antimicrobial Agents and Chemotherapy . ... which is a polymicrobial biofilm, off of the root ...
... OLEDs are already used in the displays of smart phones ... with high contrast, but come with a serious drawback: typically, ... the device is actually converted into light. This ratio can ... platinum or iridium to the active material, but these elements ...
Cached Biology News:NSF awards to UT Arlington researchers will fuel sustainable solutions 2Drug may guard against periodontitis, and related chronic diseases 2Novel LEDs pave the way to cheaper displays 2
(Date:5/6/2015)... EDISON, N.J. , May 6, 2015 Bone ... $2M funding round with Hankey Capital, LLC ("Hankey Capital") of ... developing a proprietary protein for use in bone regenerative medicine ... Nell-1) for use with patients undergoing spinal fusion. ... "We are pleased with the completion of this round of ...
(Date:5/6/2015)... Follow us on LinkedIn ... with diameter ranging between 2 to 10 nanometers, ... materials market. The unique electroluminescent, photoluminescent, photo-physical, and ... confinement effect render the nanoparticles versatile and flexible ... technological, and commercial applications. A host of value-added ...
(Date:5/6/2015)... -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of ... Cassian Yee , M.D., Professor, Department of Melanoma ... of Texas MD Anderson Cancer Center joined its scientific ... Immunology, Division of Cancer Medicine, and Director, Solid Tumor ... University of Texas MD Anderson Cancer Center.  ...
(Date:5/6/2015)... Dr Jaspreet Singh , Senior Research ... a speech at the 2015 Asian Starch Conference, to be ... Center.  , ... topic: ,Potato Starch: A Potential Source for the Creation ... Co-editor of a 528 page text book entitled "Advances ...
Breaking Biology Technology:Bone Biologics Corp Completes Financing With Hankey Capital, LLC 2Bone Biologics Corp Completes Financing With Hankey Capital, LLC 3Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Potato Starch: A Potential Source for the Creation of Next Generation Bulk-ingredients and Smart Foods 2
... Pharmaceuticals wins the EFQM Excellence Awards 2011, the first ... by EFQM, the award recognizes business performance measured against ... Model. Another 9 organisations received Prizes for role model ... Excellence. 118 independent assessors visited 20 organisations ...
... and IPSWICH, Mass., Oct. 25, 2011 SwitchGear ... services for studying regulatory elements in the human genome, ... Inc. (NEB) to create a new dual reporter assay ... Luciferase Assay System and NEB,s BioLux® Cypridina ...
... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ... today that its work entitled "Evaluation of the Safety ... Volunteers" will be presented at the Eleventh Annual Meeting ... San Francisco, California. "The selection of Oramed ...
Cached Biology Technology:1 Award Winner and 9 Prize Winners in the EFQM Business Excellence Awards 2SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System 2Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA) 2
Goat polyclonal to Centaurin alpha 2**...
... background ,This solution greatly enhances antigen-antibody reactions, ... obtained with conventional methods. ,Two kinds of ... antibodies, which can suppress the background and ... versatility ,It is applicable to various assay ...
Monocarboxylate (lactate) transporter 2...
Mouse anti human pro-Relaxin-2...
Biology Products: